Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments

por Agbarya, Abed, Sarel, Ina, Ziv-Baran, Tomer, Schwartz, Orna, Shechtman, Yelena, Kozlener, Ella, Khoury, Rasha, Sheikh-Ahmad, Mohammad, Saiegh, Leonard, Swaid, Forat, Ahmad, Asala Abu, Janzic, Urska, Brenner, Ronen
Publicado 2023